Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) Shares Outstanding (Weighted Average) (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $90.5 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 1.23% year-over-year to $90.5 million; the TTM value through Mar 2026 reached $90.5 million, down 1.23%, while the annual FY2025 figure was $90.7 million, 1.0% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $90.5 million in Q1 2026 for Acadia Healthcare Company, roughly flat from $90.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $91.7 million in Q3 2024 and bottomed at $89.3 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $90.7 million, with a median of $90.7 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Weighted Average) rose 1.74% in 2023 and then decreased 1.42% in 2025.
  • Acadia Healthcare Company's Shares Outstanding (Weighted Average) stood at $89.7 million in 2022, then increased by 1.42% to $90.9 million in 2023, then increased by 0.74% to $91.6 million in 2024, then dropped by 1.0% to $90.7 million in 2025, then dropped by 0.19% to $90.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $90.5 million, $90.7 million, and $90.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.